생화학분자생물학회입니다.
Radiation-induced liver disease: current understanding and future perspectives
작성자
관리자작성일자
2020-11-23조회수
121Youngmi Jung (y.jung@pusan.ac.kr) | ||
2014-present | Associate Professor, Department of Biology, Pusan National University, South Korea | |
2010-2014 | Assistant Professor, Department of Biology, Pusan National University, South Korea | |
2008-2010 | Assistant Professor, Department of Medicine, Division of Gastroenterology, Duke University, USA | |
2006-2008 | Research Associate, Department of Medicine, Division of Gastroenterology, Duke University, USA | |
2002-2006 | PhD, College of Medicine, Department of Pathology, Immunology, and laboratory medicine, University of Florida, USA | |
1997-1999 | MS, College of Medicine, Department of Pathology, Seoul National University, South Korea | |
Radiation-induced liver disease: current understanding and future perspectives
Although radiotherapy (RT) is used for the treatment of cancers including liver cancer, radiation-induced liver disease (RILD) has emerged as a major limitation of RT. Radiation-induced toxicities on nontumorous liver tissues are associated with the development of numerous symptoms which may limit the course of therapy or have serious chronic side effects including late fibrosis. Although the clinical characteristics of RILD patients have been relatively well described, understanding of RILD pathogenesis has been hampered by a lack of reliable animal models for RILD. Despite efforts to develop suitable experimental animal models for RILD, current animal models rarely present hepatic veno-occlusive disease, the pathological hallmark of human RILD patients, giving highly variable results in RILD-related studies. Herein, we introduce the concept and clinical characteristics of RILD and put forward a feasible explanation for RILD pathogenesis. In addition, currently available animal models of RILD are reviewed, focusing on their similarity with human RILD and clues to understanding the mechanisms of RILD progression. Based on these findings from RILD research, we present potential therapeutic strategies against RILD and prospects for future RILD studies. Therefore, this review helps to broaden our understanding in developing effective treatment strategies for RILD.
Exp Mol Med. 2017 Jul 21;49(7):e359. doi: 10.1038/emm.2017.85.
https://www.ncbi.nlm.nih.gov/pubmed/28729640